Hybrid modeling for quality by design and PAT-benefits and challenges of applications in biopharmaceutical industry.

This report highlights the drivers, challenges, and enablers of the hybrid modeling applications in biopharmaceutical industry. It is a summary of an expert panel discussion of European academics and industrialists with relevant scientific and engineering backgrounds. Hybrid modeling is viewed in its broader sense, namely as the integration of different knowledge sources in form of parametric and nonparametric models into a hybrid semi-parametric model, for instance the integration of fundamental and data-driven models. A brief description of the current state-of-the-art and industrial uptake of the methodology is provided. The report concludes with a number of recommendations to facilitate further developments and a wider industrial application of this modeling approach. These recommendations are limited to further exploiting the benefits of this methodology within process analytical technology (PAT) applications in biopharmaceutical industry.

[1]  Andreas Lübbert,et al.  Hybrid Process Modeling for Advanced Process State Estimation, Prediction, and Control Exemplified in a Production-Scale Mammalian Cell Culture , 1996 .

[2]  Adrian Oehmen,et al.  The relationship between mixed microbial culture composition and PHA production performance from fermented molasses. , 2014, New biotechnology.

[3]  Anthony G. Wedd,et al.  Mo–Cu metal cluster formation and binding in an orange protein isolated from Desulfovibrio gigas , 2014, JBIC Journal of Biological Inorganic Chemistry.

[4]  J. L. Martinez-Hurtado,et al.  Biosimilars: Company Strategies to Capture Value from the Biologics Market , 2012, Pharmaceuticals.

[5]  T. Catarino,et al.  Evidence for interaction between the triheme cytochrome PpcA from Geobacter sulfurreducens and anthrahydroquinone-2,6-disulfonate, an analog of the redox active components of humic substances. , 2014, Biochimica et Biophysica Acta.

[6]  Manuel J T Carrondo,et al.  Adenovirus purification by two-column, size-exclusion, simulated countercurrent chromatography. , 2014, Journal of chromatography. A.

[7]  Helena Lopes,et al.  Biomass fly ashes as low-cost chemical agents for Pb removal from synthetic and industrial wastewaters. , 2014, Journal of colloid and interface science.

[8]  M. Stosch,et al.  Fast development of Pichia pastoris GS115 Mut+ cultures employing batch-to-batch control and hybrid semi-parametric modeling , 2014, Bioprocess and Biosystems Engineering.

[9]  Carl-Fredrik Mandenius,et al.  Quality-by-design for biotechnology-related pharmaceuticals. , 2009, Biotechnology journal.

[10]  Venkat Venkatasubramanian,et al.  Population Balance Model-Based Hybrid Neural Network for a Pharmaceutical Milling Process , 2010, Journal of Pharmaceutical Innovation.

[11]  Rimvydas Simutis,et al.  Bioprocess optimization and control: Application of hybrid modelling , 1994 .

[12]  R. Simutis,et al.  Product formation kinetics in genetically modified E. coli bacteria: inclusion body formation , 2008, Bioprocess and biosystems engineering.

[13]  Sebastião Feyo de Azevedo,et al.  Hybrid semi-parametric modeling in process systems engineering: Past, present and future , 2014, Comput. Chem. Eng..

[14]  Rui Oliveira,et al.  Dynamic metabolic modelling of volatile fatty acids conversion to polyhydroxyalkanoates by a mixed microbial culture. , 2014, New biotechnology.

[15]  Benilde Mendes,et al.  Bio-oil upgrading strategies to improve PHA production from selected aerobic mixed cultures. , 2014, New biotechnology.

[16]  Krist V. Gernaey,et al.  A model-based systems approach to pharmaceutical product-process design and analysis , 2010 .

[17]  Michael Ringel,et al.  What matters most in commercial success: first-in-class or best-in-class? , 2013, Nature Reviews Drug Discovery.

[18]  Rimvydas Simutis,et al.  Hybrid process models for process optimisation, monitoring and control , 2004, Bioprocess and biosystems engineering.

[19]  Dakuo He,et al.  Batch-to-batch control of particle size distribution in cobalt oxalate synthesis process based on hybrid model , 2012 .

[20]  Ana P. Teixeira,et al.  Modelling and optimization of a recombinant BHK-21 cultivation process using hybrid grey-box systems. , 2005, Journal of biotechnology.

[21]  S. Feyo de Azevedo,et al.  Bioprocess hybrid parametric/nonparametric modelling based on the concept of mixture of experts , 2008 .

[22]  George M. Bollas,et al.  Using hybrid neural networks in scaling up an FCC model from a pilot plant to an industrial unit , 2003 .

[23]  Daxiang Cui,et al.  Antibody-drug gold nanoantennas with Raman spectroscopic fingerprints for in vivo tumour theranostics. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Adelaide Fernandes,et al.  Microglia change from a reactive to an age-like phenotype with the time in culture , 2014, Front. Cell. Neurosci..

[25]  Juan J de Pablo,et al.  Endohedral confinement of a DNA dodecamer onto pristine carbon nanotubes and the stability of the canonical B form. , 2014, The Journal of chemical physics.

[26]  Vladimir Mahalec,et al.  Inferential monitoring and optimization of crude separation units via hybrid models , 2012, Comput. Chem. Eng..

[27]  P. R. Patnaik.  Hybrid neural simulation of a fed-batch bioreactor for a nonideal recombinant fermentation , 2001 .

[28]  M. von Stosch,et al.  Hybrid modeling framework for process analytical technology: Application to Bordetella pertussis cultures , 2012, Biotechnology progress.

[29]  Mohd Azlan Hussain,et al.  Control of a Batch Polymerization System Using Hybrid Neural Network - First Principle Model , 2008 .

[30]  Max O. Souza,et al.  Discrete and continuous SIS epidemic models: A unifying approach , 2014 .

[31]  Carl-Fredrik Mandenius,et al.  Process analytical technology (PAT) for biopharmaceuticals , 2011, Biotechnology journal.

[32]  Catarina S. S. Oliveira,et al.  Response of a three-stage process for PHA production by mixed microbial cultures to feedstock shift: impact on polymer composition. , 2014, New biotechnology.

[33]  Lyle H. Ungar,et al.  A hybrid neural network‐first principles approach to process modeling , 1992 .

[34]  Sebastião Feyo de Azevedo,et al.  A general hybrid semi-parametric process control framework , 2012 .

[35]  Mark A. Kramer,et al.  Modeling chemical processes using prior knowledge and neural networks , 1994 .

[36]  R. Simutis,et al.  THE USE OF HYBRID MODELLING FOR THE OPTIMIZATION OF THE PENICILLIN FERMENTATION PROCESS , 1996 .

[37]  Gary Montague,et al.  Application of agent‐based system for bioprocess description and process improvement , 2008, KES.

[38]  Wee Chew,et al.  Trends in process analytical technology , 2010 .

[39]  Robert J. Huggett.  A risk‐based approach , 1996 .

[40]  Andreas Schuppert,et al.  Application of Hybrid Models in Chemical Industry , 2002 .

[41]  W. Fred Ramirez,et al.  Dynamic hybrid neural network model of an industrial fed-batch fermentation process to produce foreign protein , 2007, Comput. Chem. Eng..

[42]  Rui Oliveira,et al.  Bioprocess Iterative Batch‐to‐Batch Optimization Based on Hybrid Parametric/Nonparametric Models , 2006, Biotechnology progress.

[43]  Kamran T. Mahmudov,et al.  Di- and tri-organotin(IV) complexes of arylhydrazones of methylene active compounds and their antiproliferative activity , 2014 .

[44]  Johan Trygg,et al.  Multi- and Megavariate Data Analysis : Part II: Advanced Applications and Method Extensions , 2006 .

[45]  Maurício Bezerra de Souza,et al.  A hybrid neural model (HNM) for the on-line monitoring of lipase production by Candida rugosa , 2007 .